Strategic Signals Weekly: February 08 – February 15, 2026
February 15, 2026
7 biotech strategic signals: 0 licensing deals, 1 strategic reviews, 6 financing events.
Independent Biotech Intelligence
Primary source data for business development, investors, and strategy teams. Trials, filings, patents, and markets - linked and traceable.
Explore the Platform →Markets & Context
Select filters and overlays to view events in context
Explore live data for
4D Molecular Therapeutics, Inc.
(FDMT)
— RxDataLab Platform
Overlay:
|
|
|
Events in View
Want to explore more companies? We cover 500+ — filings, trials, insider trades, and institutional moves, all in one view.
Signup →What's in the Platform
Primary-source data on the business of biotech. Clinical trials, regulatory filings, biotech hedge fund positioning, and insider trading — updated automatically.
Clinical Trial Tracker
Pipeline changes, trial status updates, and competitive landscape mapping across 450K+ trials.
BioHedge
Hedge fund positioning in biotech stocks, updated daily based on schedule 13 filings.
Strategic Signals
Deal activity, partnership filings, and business development signals directly from SEC filings.
Insider Activity
Executive and director trades filed with the SEC, linked to company pipelines.
Research & Resources
Recent Analysis
View all →BioHedge Weekly: February 08 – February 15, 2026
February 15, 2026
8 SEC 13D/13G filings from biotech hedge funds: 1 new positions, 5 activist filings, 8 companies affected.
The Biggest Disclosure Day in Biotech
January 17, 2026
JPM Healthcare opening day triggers more biotech 8-K filings than any other day of the year. Analysis of SEC filing patterns shows 23% of public biotechs tracked by RxDataLab disclose on a single day.
Traceable data for BD, investors, and strategy teams
RxDataLab links regulatory filings to clinical programs and markets, giving you the full picture of who’s filing, what trials they’re running, and how everything connects. Clinical trial records, SEC filings, patent data, and market feeds from primary sources. Traceable data, not commentary.
Or email directly at
info@rxdatalab.com